ARQT · Arcutis Biotherapeutics, Inc.
SELL 87%
152
Total trades
17
Insiders on record
87%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Mar 2, 2026 | Todd Watanabe | SELL | Open-market sale | 912.9K | 0.95 |
| Mar 2, 2026 | Larry Todd Edwards | SELL | Open-market sale | 90.2K | 0.90 |
| Mar 2, 2026 | Keith R Leonard | SELL | Open-market sale | 997.2K | 0.92 |
| Mar 2, 2026 | Howard Welgus | SELL | Open-market sale | 256.5K | 0.88 |
| Mar 2, 2026 | Masaru Matsuda | SELL | Open-market sale | 164.9K | 0.92 |
| Mar 2, 2026 | Latha Vairavan | SELL | Open-market sale | 69.7K | 0.95 |
| Mar 2, 2026 | Patrick Burnett | SELL | Open-market sale | 153.6K | 0.92 |
| Feb 27, 2026 | Masaru Matsuda | SELL | Open-market sale | 92.9K | 0.90 |
| Feb 4, 2026 | Patrick Burnett | SELL | Open-market sale | 252.7K | 0.94 |
| Feb 2, 2026 | Masaru Matsuda | SELL | Open-market sale | 203.6K | 0.92 |
Arcutis Biotherapeutics, Inc. has 152 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade ARQT?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.